key: cord-1052136-5832gp0q authors: Hope, Aluko A.; Evering, Teresa H. title: Post-Acute Sequelae of SARS CoV-2 infection date: 2022-02-15 journal: Infect Dis Clin North Am DOI: 10.1016/j.idc.2022.02.004 sha: d5edd87a700e50b545e7f0cda71f2d7a7be91ba0 doc_id: 1052136 cord_uid: 5832gp0q Post-Acute-Sequelae of SARS-CoV-2 (PASC) or Long COVID is an emerging syndrome characterized by multiple persisting or newly emergent symptoms following the acute phase of SARS-CoV-2 infection. For affected patients, these prolonged symptoms can have a relapsing and remitting course and may be associated with disability and frequent health care utilization. Although many symptom-driven treatments are available, management remains challenging and often requires a multidisciplinary approach. This article summarizes the emerging consensus on Definitions, epidemiology, and pathophysiology of Long COVID and discusses what is understood about the prevention, evaluation, and treatment of this syndrome. The clinical spectrum of SARS-CoV-2 infection ranges from asymptomatic to critical illness, which may include severe sepsis and acute respiratory failure 1 . When symptomatic, acute COVID-19 illness will typically last days to weeks and most of the symptoms are thought to be mediated by the replication of the virus and the initial immune response to the infection 2 . As the COVID-19 pandemic continues, it has become increasingly clear that clinical sequelae and symptoms may persist for weeks to months beyond the acute stage of SARS-CoV-2 infection for a significant proportion of patients. This chronic illness has been termed Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), post-COVID syndrome, or Long COVID. A less common postacute hyperinflammatory illness (multisystem inflammatory syndrome in children (MIS-C) and multisystem inflammatory syndrome in adults (MIS-A) has also been characterized. MIS-C and MIS-A will typically occur two to five weeks after the initial SARS-CoV-2 infection and are thought to be mediated by a dysregulated immune response 1 . Patients with these syndromes may suffer from cardiovascular, gastrointestinal, neurologic, dermatologic and mucocutaneous manifestations like Kawasaki disease 3, 4 , and is discussed further in Chapter 12. This review will highlight what is known about the epidemiology, clinical features, pathophysiology, and risk factors of Long COVID and summarize current rational approaches for diagnosis, prevention and treatment of this new syndrome based on emerging literature and expert opinion. As of this writing, there is no universally accepted case definition for Long COVID 5 Centers for Disease Control and Prevention defines post-COVID conditions as a range of health problems or symptoms experienced four or more weeks after initial infection with SARS-CoV-2 6 . The United Kingdom National Institute for Health and Care Excellence (NICE) guidance classifies the acute infection as lasting up to 4 weeks, classifies ongoing symptomatic COVID-19 as lasting up to 12 weeks and then defines post-COVID syndrome as a cluster of overlapping signs and J o u r n a l P r e -p r o o f symptoms across multiple systems that has developed during or after the initial infection and continue for more than 12 weeks after SARS-CoV-2 infection 7 . Utilizing a time frame similar to NICE, the World Health Organization (WHO) proposes a clinical case definition in which Long COVID begins 3-months from the onset of probable or confirmed SARS-CoV-2 infection 8 . All current case definitions do, however, acknowledge that Long COVID encompasses a wide range of symptoms and can persist, fluctuate, or relapse following the initial SARS-COV-2 infection or can newly appear after initial symptom resolution. Estimates of the incidence and prevalence of Long COVID symptoms vary widely across published studies. The reasons for this variability include the overall severity and spectrum of SARS-CoV-2 infection in the study population, participant socio-demographics and geographic location, the health system, and the public health infrastructure within which the study is completed, the follow-up period from the initial SARS-CoV-2 infection, the spectrum of symptoms on which the reports are based, the methods and tools for data collection and chosen study outcome measure 9 . In addition, most studies describing the prevalence and clinical manifestations of Long COVID are cross-sectional or observational and are subject to various types of selection or reporter bias that make it difficult to generalize the results beyond the population studied 10 . As an example, participation in app-based self-report surveys requires motivated participants with adequate computer literacy to download the app and track their COVID-19 symptom, thus influencing the responding cohort 11, 12 . Acknowledging the heterogeneity of these studies, in general, for those patients evaluated or treated for acute COVID-19 in the outpatient setting, the reported incidence of Long COVID ranges from 10% to 35% [13] [14] [15] and can exceed 80% for those treated in the hospital with more severe initial illness 16, 17 . In one of the earliest attempts to define the clinical course of COVID-19, a cross-sectional study of symptomatic adults tested in outpatient settings reported that 34% had not returned to their usual state of health 14-21 days after SARS-CoV-2 infection 14 . In light of the J o u r n a l P r e -p r o o f prolonged course of Long COVID, multiple studies have since followed participants for longer durations in a variety of settings. An illustrative selection of those studies is summarized in Table 1 . Taken together, these studies reveal the global scope of the syndrome and suggest the potential for a significant proportion of patients who are infected with SARS-CoV-2 regardless of severity of the initial infection to develop Long COVID. J o u r n a l P r e -p r o o f 54 . These findings support the hypothesis that premorbid vulnerability and older age play an important role in predicting longterm cognitive sequalae of SARS-Cov-2 infection. 54 In multiple cross-sectional studies 11, 37 as well as in multiple observational studies of Long COVID in treatment settings 55, 56 , women appear more likely to develop Long COVID symptoms than men 57 . Additionally, the largest cross-sectional studies of Long COVID symptoms in adults have typically shown a predominance of female participants 11, 37 however, it remains unclear if this reflects a true biologic predisposition to Long COVID, as reporter bias may also play a role. In terms of precipitating factors, perhaps not surprisingly, several studies report that the severity of the initial COVID-19 infection appears to be associated with an increased risk of developing Long COVID 11 . Similarly, length of hospitalization and ICU admission have also been identified as independent predictors of Long COVID at 6 months of follow-up 58 . In a large, prospective cross-sectional study of 558 adults who self-reported their symptoms in the COVID Symptom Study app 59 adults with more than 5 symptoms during the first week of their COVID-19 illness were more likely to experience symptoms beyond 28 days (Odds Ratio 3.95 (95% confidence interval 3.10 -5.04) 11 . In this study, in adults over 70 years of age, loss of smell, fever and hoarse voice were symptoms most predictive of developing Long COVID, with odd ratios ranging from 4.03 to 7.35 11 71 . Patients may describe severe exhaustion after minimal exertion, a lack of stamina, or feeling "weighted down". Post-exertional malaise may be described as "crashing" after several good days, or several days of worsening symptoms after stressors or triggers. Cognitive difficulties or "brain fog" can include impaired attention, concentration, reduced ability to multi-task, difficulty with short-term memory and wordfinding difficulties 72 . Some patients may describe increased irritability or emotionally vulnerability. Reports of unrestful or non-restorative sleep, often with delayed sleep onset or frequent awakening are common. Orthostatic intolerance has been reported in Long COVID 39 75 . Patients with cognitive complaints may benefit from a thorough neurologic examination to identify focal neurologic deficits. Balance and gait may be assessed and compared with age-based norms. For patients with changes in visual acuity or eye pain, a low threshold for a post-COVID-19 retinal examination seems reasonable given that the eyes are known to have ACE 2 and such examinations can be a window into microvascular alterations affecting the whole body 76, 77 . Laboratory testing should focus on ruling out co-morbid conditions, contributory factors, and common conditions that may explain reported symptoms. It may help to prepare the patient for the fact that most of these tests will be normal. Examples of useful screening tests for initial Although there are few studies of treatment in Long COVID that have shown efficacy or effectiveness, consensus guidance on best approaches to treat these patients based on the lived experience of patient and clinicians are emerging [71] [72] [73] 80 . The overall approach to treatment of Long COVID is to focus on managing symptoms, improving function, and working with the patient to settle on reasonable treatments targets that have the potential to improve their quality of life. Given the wide array and varying magnitude of presentation of Long COVID symptoms, multiprong approaches may be needed. Providing patients with the tools for self-management is crucial early in the disease course since patients are often dealing with isolation and uncertainty. The goal of self-management is to help the patient be in control of their disease and healing process. The primary care or generalists should remain integrated in the care of these patients to facilitate access to local physiotherapy, occupational therapy, dieticians, or home care. In addition, the primary care provider has an important role in searching for alternative diagnoses, so that not all the patient's symptoms are automatically attributed to this syndrome. Titrating Physical Activity: The evaluation may first focus on the patient's medical history, diagnostic tests, pre-COVID-19 level of physical activity and social determinants of health. Patients should be screened for post-exertional symptom exacerbation through careful monitoring of their symptoms both during physical activity and in the days following the activity. Signs of exertional oxygen desaturation, orthostatic intolerance or autonomic dysfunction may also be important to titrate the appropriate level and type of physical activity during the recovery process. Importantly, telling patients to push through their pain or discomfort during the early periods may understanding of evolving disease processes 51 . As the pandemic continues, addressing optimal resource allocation, the focus of care (primary vs. specialty) and the ability to scale-up will also become increasingly challenging 81 . Earlier referral may be appropriate in: younger patients; more complex patients where the diagnosis is unclear and the treatment challenging; in patients for whom the disability impact of illness is severe and in patients where local clinical support is limited. In recognition of the significant public health impact of Long COVID, the National Institute A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications Post-acute COVID-19 syndrome Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection -United Kingdom and United States Multisystem Inflammatory Syndrome in U.S. Children and Adolescents Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19 effects/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2 F2019-ncov%2Flong-term-effects.html) Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline Long covid-mechanisms, risk factors, and management Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity Attributes and predictors of long COVID Rapid implementation of mobile technology for real-time epidemiology of COVID-19 Management of post-acute covid-19 in primary care Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network -United States Sequelae in Adults at 6 Months After COVID-19 Infection Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study Long COVID: current definition Follow-up of adults with noncritical COVID-19 two months after symptom onset Persistent Symptoms in Patients After Acute COVID-19 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? Long COVID in a prospective cohort of homeisolated patients Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review Syndrome: A systematic review and meta-analysis Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know? A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome Effects of COVID-19 on the Nervous System Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 More than 50 long-term effects of COVID-19: a systematic review and meta-analysis From heart to muscle: Pathophysiological mechanisms underlying long-term physical sequelae from SARS-CoV-2 infection Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 Continuing Cardiopulmonary Symptoms, Disability, and Financial Toxicity 1 Month After Hospitalization for Third-Wave COVID-19: Early Results From a US Nationwide Cohort Characterizing long COVID in an international cohort: 7 months of symptoms and their impact Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing Respiratory follow-up of patients with COVID-19 pneumonia Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up Post-acute sequelae of SARS-CoV-2 infection (PASC): peripheral, autonomic, and central nervous system features in a child Extrapulmonary manifestations of COVID-19 Central sensitization syndrome and the initial evaluation of a patient with fibromyalgia: a review Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome Psychiatric and neuropsychiatric sequelae of COVID-19 -A systematic review Disturbances in sleep, circadian rhythms and daytime functioning in relation to coronavirus infection and Long-COVID -A multinational ICOSS study Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers What's new in post-ICU cognitive impairment? The International Collaborative on Fatigue Following Infection (COFFI) Patient management of post-viral fatigue syndrome Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness COVID-19 Mechanisms in the Human Body-What We Know So Far Premorbid vulnerability and disease severity impact on Long-COVID cognitive impairment Risk Factors Associated with Long COVID Syndrome: A Retrospective Study Female gender is associated with long COVID syndrome: a prospective cohort study Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect Real-time tracking of self-reported symptoms to predict potential COVID-19 ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Evolution of antibody immunity to SARS-CoV-2 Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis Predictors of Prolonged Cardiopulmonary Exercise Impairment After COVID-19 Infection: A Prospective Observational Study Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID Covid-19 and autoimmunity Long-term complications of COVID-19 Persistent Autoimmune Activation and Proinflammatory State in Post-COVID Syndrome Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC) Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome EFNS guidelines on the diagnosis and management of orthostatic hypotension Retinal findings in patients with COVID-19: Results from the SERPICO-19 study Retinal vessels modifications in acute and post-COVID-19 Risk factors and disease profile of postvaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a J o u r n a l P r e -p r o o f prospective, community-based, nested, case-control study Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians The Next Challenge for Post-COVID-19 Natinal Institutes of Health. NIH launches new initiative to study "Long COVID World Health Organization. Global COVID-19 Clinical Platform Case REport Form for Post COVID condition (Post COVID-19 CRF) Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases Persistent Autoimmune Activation and Proinflammatory State in Post-COVID Syndrome. The Journal of infectious diseases